Multicenter phase II study of gemcitabine and oxaliplatin (GEMOX) as second-line chemotherapy in colorectal cancer patients pretreated with 5-fluorouracil plus irinotecan.
about
Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial.Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review.Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patientsGemox: a widely useful therapy against solid tumors-review and personal experience.
P2860
Multicenter phase II study of gemcitabine and oxaliplatin (GEMOX) as second-line chemotherapy in colorectal cancer patients pretreated with 5-fluorouracil plus irinotecan.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Multicenter phase II study of ...... -fluorouracil plus irinotecan.
@ast
Multicenter phase II study of ...... -fluorouracil plus irinotecan.
@en
type
label
Multicenter phase II study of ...... -fluorouracil plus irinotecan.
@ast
Multicenter phase II study of ...... -fluorouracil plus irinotecan.
@en
prefLabel
Multicenter phase II study of ...... -fluorouracil plus irinotecan.
@ast
Multicenter phase II study of ...... -fluorouracil plus irinotecan.
@en
P2093
P2860
P356
P1433
P1476
Multicenter phase II study of ...... -fluorouracil plus irinotecan.
@en
P2093
A Potamianou
C Christofillakis
E Tselepatiotis
I Boukovinas
I Varthalitis
V Georgoulias
P2860
P304
P356
10.1159/000092956
P577
2006-04-25T00:00:00Z